{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:31:02Z","timestamp":1789133462687,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,3,31]],"date-time":"2009-03-31T00:00:00Z","timestamp":1238457600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1038\/sj.bjc.6605011","type":"journal-article","created":{"date-parts":[[2009,3,31]],"date-time":"2009-03-31T20:01:03Z","timestamp":1238529663000},"page":"1315-1319","source":"Crossref","is-referenced-by-count":224,"title":["Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts"],"prefix":"10.1038","volume":"100","author":[{"given":"K","family":"Huhtinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Suvitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hiissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Junnila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Huvila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kujari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Set\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"H\u00e4rkki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Jalkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"M\u00e4kinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Auranen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Poutanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Perheentupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,31]]},"reference":[{"key":"BF6605011_CR1","doi-asserted-by":"crossref","unstructured":"(1997) Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67: 817\u2013821","DOI":"10.1016\/S0015-0282(97)81391-X"},{"key":"BF6605011_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","volume":"70","author":"JL Benedet","year":"2000","unstructured":"Benedet JL, Bender H, Jones 3rd H, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers, FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70: 209\u2013262","journal-title":"Int J Gynaecol Obstet"},{"key":"BF6605011_CR3","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","volume":"65","author":"R Drapkin","year":"2005","unstructured":"Drapkin R, von Horsten H, Lin Y, Mok S, Crum C, Welch W, Hecht J (2005) Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res 65: 2162\u20132169","journal-title":"Cancer Res"},{"key":"BF6605011_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/GCO.0b013e3282f226a5","volume":"20","author":"A Gagnon","year":"2008","unstructured":"Gagnon A, Ye B (2008) Discovery and application of protein biomarkers for ovarian cancer. Curr Opin Obstet Gynecol 20: 9\u201313","journal-title":"Curr Opin Obstet Gynecol"},{"key":"BF6605011_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/modpathol.3800612","volume":"19","author":"M Galgano","year":"2006","unstructured":"Galgano M, Hampton G, Frierson HJ (2006) Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol 19: 847\u2013853","journal-title":"Mod Pathol"},{"key":"BF6605011_CR6","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(04)17403-5","volume":"364","author":"L Giudice","year":"2004","unstructured":"Giudice L, Kao L (2004) Endometriosis. Lancet 364: 1789\u20131799","journal-title":"Lancet"},{"key":"BF6605011_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ygyno.2008.04.041","volume":"110","author":"L Havrilesky","year":"2008","unstructured":"Havrilesky L, Whitehead C, Rubatt J, Cheek R, Groelke J, He Q, Malinowski D, Fischer T, Berchuck A (2008) Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence. Gynecol Oncol 110: 374\u2013382","journal-title":"Gynecol Oncol"},{"key":"BF6605011_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-0-387-68969-2_2","volume":"622","author":"I Hellstr\u00f6m","year":"2008","unstructured":"Hellstr\u00f6m I, Hellstr\u00f6m K (2008) SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and\/or each other. Adv Exp Med Biol 622: 15\u201321","journal-title":"Adv Exp Med Biol"},{"key":"BF6605011_CR9","first-page":"3695","volume":"63","author":"I Hellstr\u00f6m","year":"2003","unstructured":"Hellstr\u00f6m I, Raycraft J, Hayden-Ledbetter M, Ledbetter J, Schummer M, McIntosh M, Drescher C, Urban N, Hellstr\u00f6m K (2003) The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res 63: 3695\u20133700","journal-title":"Cancer Res"},{"key":"BF6605011_CR10","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1093\/humrep\/deh890","volume":"20","author":"J Kitawaki","year":"2005","unstructured":"Kitawaki J, Ishihara H, Koshiba H, Kiyomizu M, Teramoto M, Kitaoka Y, Honjo H (2005) Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas. Hum Reprod 20: 1999\u20132003","journal-title":"Hum Reprod"},{"key":"BF6605011_CR11","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1158\/1055-9965.EPI-08-0150","volume":"17","author":"KA Lowe","year":"2008","unstructured":"Lowe KA, Shah C, Wallace E, Anderson G, Paley P, McIntosh M, Andersen MR, Scholler N, Bergan L, Thorpe J, Urban N, Drescher CW (2008) Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev 17: 2480\u20132487","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6605011_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1634\/theoncologist.2-1-6","volume":"2","author":"M Markman","year":"1997","unstructured":"Markman M (1997) The role of CA-125 in the management of ovarian cancer. Oncologist 2: 6\u20139","journal-title":"Oncologist"},{"key":"BF6605011_CR13","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S0015-0282(98)00355-0","volume":"70","author":"B Mol","year":"1998","unstructured":"Mol B, Bayram N, Lijmer J, Wiegerinck M, Bongers M, van der Veen F, Bossuyt P (1998) The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 70: 1101\u20131108","journal-title":"Fertil Steril"},{"key":"BF6605011_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ygyno.2008.04.002","volume":"110","author":"R Moore","year":"2008","unstructured":"Moore R, Brown A, Miller M, Badgwell D, Lu Z, Allard W, Granai C, Bast RJ, Lu K (2008b) Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus. Gynecol Oncol 110: 196\u2013201","journal-title":"Gynecol Oncol"},{"key":"BF6605011_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","volume":"108","author":"R Moore","year":"2008","unstructured":"Moore R, Brown A, Miller M, Skates S, Allard W, Verch T, Steinhoff M, Messerlian G, DiSilvestro P, Granai C, Bast RJ (2008a) The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass. Gynecol Oncol 108: 402\u2013408","journal-title":"Gynecol Oncol"},{"key":"BF6605011_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","volume":"112","author":"R Moore","year":"2009","unstructured":"Moore R, McMeekin D, Brown A, DiSilvestro P, Miller M, Allard W, Gajewski W, Kurman R, Bast RJ, Skates S (2009) A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol 112: 40\u201346","journal-title":"Gynecol Oncol"},{"key":"BF6605011_CR17","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.ejca.2008.07.009","volume":"44","author":"C Nagle","year":"2008","unstructured":"Nagle C, Olsen C, Webb P, Jordan S, Whiteman D, Green A (2008) Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors. Eur J Cancer 44: 2477\u20132484","journal-title":"Eur J Cancer"},{"key":"BF6605011_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1067\/mob.2003.408","volume":"189","author":"R Ness","year":"2003","unstructured":"Ness R (2003) Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol 189: 280\u2013294","journal-title":"Am J Obstet Gynecol"},{"key":"BF6605011_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0015-0282(97)00191-X","volume":"68","author":"M Nisolle","year":"1997","unstructured":"Nisolle M, Donnez J (1997) Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril 68: 585\u2013596","journal-title":"Fertil Steril"},{"key":"BF6605011_CR20","first-page":"7052","volume":"60","author":"N Sato","year":"2000","unstructured":"Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, Noguchi M (2000) Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 60: 7052\u20137056","journal-title":"Cancer Res"},{"key":"BF6605011_CR21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.fertnstert.2007.05.014","volume":"89","author":"B Seeber","year":"2008","unstructured":"Seeber B, Sammel M, Fan X, Gerton G, Shaunik A, Chittams J, Barnhart K (2008) Panel of markers can accurately predict endometriosis in a subset of patients. Fertil Steril 89: 1073\u20131081","journal-title":"Fertil Steril"},{"key":"BF6605011_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1155\/2004\/241982","volume":"20","author":"K Terry","year":"2004","unstructured":"Terry K, Sluss P, Skates S, Mok S, Ye B, Vitonis A, Cramer D (2004) Blood and urine markers for ovarian cancer: a comprehensive review. Dis Markers 20: 53\u201370","journal-title":"Dis Markers"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605011.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605011","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605011.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:39:11Z","timestamp":1684413551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,31]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["BF6605011"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605011","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,31]]}}}